5.82
Imagenebio Inc Aktie (IMA) Neueste Nachrichten
IMA stock surges 24%, breaks 50-DMA for first time since February – what's driving the rally? - MSN
ImageneBio (IMA) Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelineCommunity Breakout Alerts - Newser
IMA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineCommunity Trading Platform - Newser
IMA Technical Analysis | Trend, Signals & Chart Patterns | IMAGENEBIO INC (NASDAQ:IMA) - ChartMill
ImageneBio (IMA) Q1 2026 Results Fall Short — EPS $-0.95, Revenue $N/AExpert Stock Picks - Newser
ImageneBio (IMA) Q1 2026 Stumbles — EPS $-0.95 Misses TargetReturn On Assets - Newser
Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to Trade - MSN
ImageneBio $30 million private placement ignites stock - MSN
BVF-affiliated entities hold up to 1.11M shares in ImageneBio (IMA) - Stock Titan
ImageneBio stock jumps on $30M financing - MSN
Blue Owl Capital (IMA) reports 959,337 shares, 8.51% stake in ImageneBio - Stock Titan
Why ImageneBio (IMA) could be the anchor your portfolio needs (Tick Up) 2026-05-11Earnings Breakout - Newser
Wedbush Reiterates Underperform Rating for ImageneBio (NASDAQ:IMA) - MarketBeat
ImageneBio (NASDAQ:IMA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Leerink Partners Maintains ImageneBio(IMA.US) With Buy Rating, Cuts Target Price to $24 - Moomoo
William Blair Maintains ImageneBio(IMA.US) With Buy Rating - Moomoo
IMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
2.5M shares for resale by selling holders — ImageneBio (NASDAQ: IMA) - Stock Titan
ImageneBio reports Q1 2026 net loss of $10.6M, $117.2M cash on hand after $30M private placement - TradingView
ImageneBio (NASDAQ: IMA) posts larger Q1 loss but holds $117M cash - Stock Titan
ImageneBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ImageneBio (Nasdaq: IMA) Q1 2026 loss and OX40 program update - Stock Titan
With $30M raised, ImageneBio plans 2026 Phase 2 hair-loss study - Stock Titan
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update - marketscreener.com
ImageneBio (NASDAQ: IMA) registers 2,508,337 resale shares - Stock Titan
ImageneBio Inc expected to post a loss of 70 cents a shareEarnings Preview - TradingView
IMA SEC FilingsImageneBio 10-K, 10-Q, 8-K Forms - Stock Titan
IMA Price Today: ImageneBio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
ImageneBio (NASDAQ: IMA) plans 2026 virtual meeting and equity plan vote - Stock Titan
[ARS] ImageneBio, Inc. SEC Filing - Stock Titan
OrbiMed adds pre-funded warrants in ImageneBio (IMA) 2026 PIPE - Stock Titan
IMA (ImageneBio) shares rise 2.42% after posting a narrower than expected Q4 2025 loss.Shared Buy Zones - newser.com
Short Interest in ImageneBio, Inc. (NASDAQ:IMA) Increases By 51.7% - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):